These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7157557)

  • 1. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine in management of large pituitary tumours.
    Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
    Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of pituitary adenomas.
    Baskin DS; Wilson CB
    Neurosurgery; 1981 Jun; 8(6):741-4. PubMed ID: 7279165
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
    Lundberg PO; Bergström K; Thuomas KA; Muhr C; Enoksson P
    Acta Radiol Suppl; 1986; 369():310-3. PubMed ID: 2980483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bromocriptine on pituitary tumour size.
    McGregor AM; Scanlon MF; Hall R; Hall K
    Br Med J; 1979 Sep; 2(6192):700-3. PubMed ID: 509071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
    Woodhouse NJ; Khouqueer F; Sieck JO
    Horm Res; 1981; 14(3):141-7. PubMed ID: 7286886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gonadotropic pituitary adenoma and pregnancy. Value of bromocriptine].
    Robert M; Leriche-Polverelli A; Hamon P; Labat-Moleur F; Tourniaire J
    Presse Med; 1991 Mar; 20(11):503-6. PubMed ID: 1827188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
    Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
    Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M; Ventz M; Meng W
    Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia in males with and without pituitary macroadenomas.
    Spark RF; Wills CA; O'Reilly G; Ransil BJ; Bergland R
    Lancet; 1982 Jul; 2(8290):129-32. PubMed ID: 6123841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia.
    Grossman A; Bouloux PM; Loneragan R; Rees LH; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1985 May; 22(5):611-6. PubMed ID: 4028459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia in men-response to bromocriptine therapy.
    Prescott RW; Johnston DG; Kendall-Taylor P; Crombie A; Hall K; McGregor A; Hall R
    Lancet; 1982 Jan; 1(8266):245-8. PubMed ID: 6120274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
    Bergh T; Nillius SJ; Enoksson P; Wide L
    J Endocrinol Invest; 1984 Apr; 7(2):133-6. PubMed ID: 6725868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.